C. Diff (Clostridium Difficile) Clinical Trial
What is Clostridium difficile?
C. difficile (C. diff) is one of the most common causes of healthcare-related infections.
C. diff is a type of bacteria that lives in the human intestines and its spores can survive outside of the body for months. These spores are resistant to cleaning and are most commonly transmitted in healthcare settings. People can become infected by touching surfaces that are contaminated or by coming into contact with a healthcare worker that has the bacteria or spores on their hands.
People most at risk of getting sick due to C. diff are those who are taking antibiotics, being treated in a healthcare facility, the elderly and people who are already ill. This infection can cause symptoms that include frequent diarrhea, inflammation of the colon, fever, nausea and abdominal pain; in severe cases it can be life-threatening.
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.
Compensation for Time and Travel
All study related visits, care, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided. Please contact us for more information as it varies by each study.
C. Diff Study #P05
About the Study
A phase III, placebo-controlled, randomized, observer-blinded study to evaluate the efficacy, safety, and tolerability of a clostridium difficile vaccine in adults 60 years of age and older
Eligibility to Participate
Have you received oral or injectable antibiotics at any time in
the last 12 weeks? Or
Have you had at least 2 visits to the emergency room, or had a
hospitalization of at least 2 nights in the last 12 months? Or
Do you have a planned surgery that will require a hospital stay
of 2 nights or more? Or
Have you been to the doctor more than 10 times in the last year? Or
Are you a resident in a nursing facility? Or
If you are at least 60 years of age and answered YES to any of the questions above, you may be eligible to participate in this study to evaluate the effectiveness of an investigational vaccine for reducing the chance of getting C. diff.
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.
C. Diff Study #S12
About the Study
A Phase III Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety, Tolerability, and Efficacy of SER 109 vs. Placebo to Reduce Recurrence of Clostridium difficile Infection (CDI) in Adults Who Have Received Antibacterial Drug Treatment for Recurrent CDI (RCDI)
Eligibility to Participate
Be 18 years of age or older
Have a documented history of at least 3 episodes of C. Diff Infection in the last 12 months, including your current episode
Contact us for a no cost assessment to determine if you may qualify for this study.
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.